[

biontech se

]
Taiwan's medical system is coming under increasing strain due to a spike in domestic infections. Photographer: Billy H.C. Kwok/Bloomberg(Bloomberg)

Taiwan says request to drop word 'country' led to BioNTech vaccine deal collapse

Reuters | , Taipei
PUBLISHED ON MAY 27, 2021 02:58 PM IST
  • "BioNTech suddenly sent a letter, saying they strongly recommend us to change the word 'our country' in the Chinese version of the press release,"
Ugur Sahin said his company is working to further expand its manufacturing network with its own sites. REUTERS/Ralph Orlowski/File Photo(REUTERS)
Ugur Sahin said his company is working to further expand its manufacturing network with its own sites. REUTERS/Ralph Orlowski/File Photo(REUTERS)

Vaccine maker BioNTech says no need to waive patents

AP | , Berlin
PUBLISHED ON MAY 10, 2021 08:27 PM IST
  • Ugur Sahin, the chief executive of BioNTech, rejected the US-backed proposal to temporarily lift some intellectual property rights for vaccines in order to boost global supply during the ongoing pandemic.
BioNTech said its expansion plans were supported by the Singapore Economic Development Board and would increase the global supply of mRNA-based vaccines. (AP Photo/Michael Probst, file)(AP)
BioNTech said its expansion plans were supported by the Singapore Economic Development Board and would increase the global supply of mRNA-based vaccines. (AP Photo/Michael Probst, file)(AP)

BioNTech to build mRNA vaccine manufacturing site in Singapore

Reuters | , Berlin
PUBLISHED ON MAY 10, 2021 12:16 PM IST
BioNTech plans to open the Singapore office in 2021 and expects the manufacturing site to be operational by 2023, creating up to 80 jobs in Singapore.
Coronavirus vaccines from Pfizer, BioNTech neutralises Covid-19 Brazil variant(Twitter/consumerconnekt)
Coronavirus vaccines from Pfizer, BioNTech neutralises Covid-19 Brazil variant(Twitter/consumerconnekt)

Coronavirus vaccines from Pfizer, BioNTech neutralises Covid-19 Brazil variant

Reuters |
UPDATED ON MAR 09, 2021 08:23 AM IST
Pfizer has said it believes its current Covid-19 vaccine is highly likely to still protect against the South African variant but is planning to test a third booster dose of it as well as a version retooled specifically to combat the variant in order to better understand the immune response
A scientist works in the providing lipid nanoparticle delivery system in the development of the Pfizer BioNtech Covid-19 vaccine. (Representative Image)(Bloomberg)
A scientist works in the providing lipid nanoparticle delivery system in the development of the Pfizer BioNtech Covid-19 vaccine. (Representative Image)(Bloomberg)

BioNTech starts production at new Covid-19 vaccine plant in Germany

Bloomberg |
PUBLISHED ON FEB 10, 2021 03:05 PM IST
The first batch produced at the site in Marburg, north of Frankfurt, enough for 8 million doses, is scheduled for distribution in early April, BioNTech said in a statement.
FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph Orlowski/File Photo(REUTERS)
FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph Orlowski/File Photo(REUTERS)

Merck KGaA to help BioNTech for faster Covid-19 vaccination drive

Bloomberg |
PUBLISHED ON FEB 05, 2021 03:35 PM IST
Merck is one of the world’s main suppliers of the custom lipid nanoparticles that are crucial to producing shots using messenger-RNA technology.
Pfizer's previous production target for 2021 was 1.3 billion doses of their Covid-19 vaccine.(Bloomberg)
Pfizer's previous production target for 2021 was 1.3 billion doses of their Covid-19 vaccine.(Bloomberg)

Pfizer, BioNTech boost Covid-19 vaccine target to 2 billion doses

Bloomberg |
PUBLISHED ON JAN 11, 2021 06:33 PM IST
A new production site in Marburg, Germany, expected to become operational by the end of February will be able to make as many as 750 million doses per year.
The Pfizer Covid-19 vaccine has been approved by several countries (REUTERS)
The Pfizer Covid-19 vaccine has been approved by several countries (REUTERS)

Covid-19 vaccine update: Pan-India dry run on Saturday, WHO approves Pfizer’s candidate

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Karan Manral
UPDATED ON JAN 01, 2021 10:58 AM IST
The European Union (EU) will review a request by Pfizer’s German partner, BioNTech SE, for an additional vaccine dose from each vial, instead of the five currently approved.
A nurse prepares a Pfizer COVID-19 vaccine to be administered to elderly people in Soroka Hospital in Beersheba, Israel, Tuesday, Dec. 29, 2020. (AP Photo/Tsafrir Abayov)
A nurse prepares a Pfizer COVID-19 vaccine to be administered to elderly people in Soroka Hospital in Beersheba, Israel, Tuesday, Dec. 29, 2020. (AP Photo/Tsafrir Abayov)

Covid-19 vaccination: Singapore, Ireland commence immunisation drives

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Karan Manral
UPDATED ON DEC 30, 2020 10:30 AM IST
Iran has started its first study of the safety and effectiveness of a Covid-19 vaccine, a locally developed candidate.
Maria Irene Ramirez receives the first injection with a dose of the Pfizer/BioNtech COVID-19 vaccine at General Hospital, as the coronavirus disease (COVID-19) outbreak continues, in Mexico City, Mexico December 24, 2020. REUTERS/Edgard Garrido
Maria Irene Ramirez receives the first injection with a dose of the Pfizer/BioNtech COVID-19 vaccine at General Hospital, as the coronavirus disease (COVID-19) outbreak continues, in Mexico City, Mexico December 24, 2020. REUTERS/Edgard Garrido

Covid-19 vaccination: From India to Morocco, here’s where some countries stand

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Karan Manral
UPDATED ON DEC 25, 2020 03:48 PM IST
Vaccination drives against Covid-19 have already commenced in several countries.
A Covid-19 Pfizer-BioNTech vaccine (AP Photo/Nam Y. Huh)
A Covid-19 Pfizer-BioNTech vaccine (AP Photo/Nam Y. Huh)

Netherlands aims to begin Pfizer-BioNTech shots by January 8, says health minister

The Hague | By Associated Press | Posted by Karan Manral
UPDATED ON DEC 18, 2020 10:33 AM IST
Dutch Health minister Hugo de Jonge said that health authorities have developed a plan he described as “careful, safe and responsible.”
Mike Pence will get the shot during a White House event to “build confidence among the American people,” his office said in a statement(REUTERS)
Mike Pence will get the shot during a White House event to “build confidence among the American people,” his office said in a statement(REUTERS)

Mike Pence, Joe Biden to get vaccine to build public confidence in shot

Washington | By Bloomberg | Posted by Ayshee Bhaduri
UPDATED ON DEC 17, 2020 08:36 AM IST
Pence and Biden stand in contrast to President Donald Trump, who has wavered about whether and when he will receive the vaccine. Many public-health experts said the president should be among the dignitaries who get the shots to inspire confidence in them.
Pfizer Inc. and BioNTech SE may soon allow participants in its Covid-19 vaccine trial to learn whether they received a placebo, rather than the real thing, and get the actual shot if they wish(REUTERS)
Pfizer Inc. and BioNTech SE may soon allow participants in its Covid-19 vaccine trial to learn whether they received a placebo, rather than the real thing, and get the actual shot if they wish(REUTERS)

Pfizer may offer shots to trial volunteers who received placebo

By Bloomberg | Posted by Ayshee Bhaduri
UPDATED ON DEC 14, 2020 08:07 AM IST
A go-ahead may allow some 19,000 people who received placebos to get Pfizer’s shot, which is in short supply. Pfizer’s emergency use application provided data from 37,586 volunteers, the majority of whom were in the US, according to the FDA. Of those, 18,785 people received a saline placebo.
Syringes are seen in front of displayed Biontech and Pfizer logos in this illustration taken November 10, 2020 (REUTERS/Dado Ruvic/Illustration/File Photo)
Syringes are seen in front of displayed Biontech and Pfizer logos in this illustration taken November 10, 2020 (REUTERS/Dado Ruvic/Illustration/File Photo)

Covid-19 vaccine update: Pfizer announces 95% efficacy, Spain authorises phase 3 trial of Janssen’s candidate

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Karan Manral
UPDATED ON NOV 19, 2020 08:44 AM IST
Officials in the United States have said freezers required to store Covid-19 vaccines, once approved, are in place at health facilities that will administer initial doses.
A stock ticker with Pfizer stock information is shown at the New York Stock Exchange.(AP)
A stock ticker with Pfizer stock information is shown at the New York Stock Exchange.(AP)

Pfizer shares zoom 20% on vaccine report

By Press Trust of India | Posted by Shivani Kumar
UPDATED ON NOV 10, 2020 12:40 PM IST
The stock jumped 16.29 per cent to Rs 5,875 -- its record high -- on the BSE. At the NSE, it gained 19.83 per cent to its lifetime high of Rs 5,900.
The sun is seen behind a crude oil pump jack in the Permian Basin in Loving County, Texas, US.(Reuters)
The sun is seen behind a crude oil pump jack in the Permian Basin in Loving County, Texas, US.(Reuters)

Oil jumps by most since June on Covid-19 vaccine progress

By Bloomberg | Posted by Shivani Kumar
UPDATED ON NOV 09, 2020 06:31 PM IST
Crude futures spiked following news the vaccine, being developed by Pfizer and BioNTech SE, prevented more than 90% of infections in a study of tens of thousands of volunteers.
SHARE
Story Saved